TERT-BUTYL (3R,4S)-4-METHYLPYRROLIDIN-3-YLCARBAMATE HYDROCHLORIDE, 95.0%, 100mg

1,4-Dimethyl-3-phenyl-1h-pyrazol-5-amine, 95+%, 500mg

2-(4-Methoxyphenoxy)ethylamine hydrochloride, tech., 95.0%, 1g

2-(Bromomethyl)-4-(trifluoromethyl)thiazole, 97%, 100mg

3-(3,4-DIMETHOXYPHENYL)-2,5-DIMETHYL-N-(2-MORPHOLINOETHYL)PYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE, 95%, 5mg

(4-Chloro-pyrimidin-2-yl)-methyl-amine, 95.0%, 25g

2,6-dimetilanilina, >=98%, para síntesis, 500 ml, envase de vidrio

2-((2-(4-Bromophenyl)-6-methylpyrimidin-4-yl)amino)ethanol, 98+%, 1g

3-(tert-Butyl)picolinonitrile, 95.0%, 250mg

2-(4-(2-Methoxyethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

3-Methoxy-piperidine, 95.0%, 5g

2-(3,4-DICHLOROPHENYL)-2-PHENYLETHYLAMINE HCL, 95.0%, 250mg

Temozolomide Acid>98.0%(HPLC)50mg